Mounjaro
Mounjaro is the latest of the weight-loss injection pens and has shown the highest effectiveness in clinical trials, with an average body-weight loss of ~22.5%. This compares to ~10% with Saxenda, and ~15% with Wegovy and Ozempic.
Active ingredient: Tirzepatide.
- Start at the lowest dose and titrate up to minimise side effects.
- Starting dose: 2.5 mg; highest maintenance dose: 15 mg.
- Administration: once weekly injection.








